A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

PHASE3RecruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

June 30, 2024

Conditions
Anesthesia Induction
Interventions
DRUG

ET-26

freeze-dried powder injection,The initial dose is 0.8 mg/kg, with an additional 50% starting dose if needed. single dose, Infusion time was 60s ± 5s.

DRUG

Etomidate Injectable Emulsion

lipid emulsion ,The initial dose is 0.3 mg/kg, with an additional 50% starting dose if needed.single dose, Infusion time was 60s ± 5s.

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Ahon Pharmaceutical Co., Ltd.

OTHER